BIOSTATISTICS, ANALYTICAL SUPPORT AND EVALUATION SHARED RESOURCE (BASE) ABSTRACT The Biostatistics, Analytical Support & Evaluation Shared Resource (BASE) goal is to provide comprehensive and high quality biostatistics support for basic and translational cancer-related research, clinical trials and population studies in the UCLA Jonsson Comprehensive Cancer Center (JCCC). The BASE Shared Resource promotes excellence in cancer research by engagement in a study from its inception to its conclusion, through statistical support on study design, data analysis, interpretation of study results, and manuscript preparation. BASE services for JCCC members also includes statistical study design prior to a grant application, with BASE statisticians supported as co-investigators when funding occurs. BASE supports two critical JCCC standing committees: the Internal Scientific Protocol Review Committee (ISPRC), by providing statistical review of clinical trials protocols, and the Data & Safety Monitoring Board (DSMB), by providing statistical support for the implementation, conduct, and monitoring of oncology clinical trials. In addition, the BASE Shared Resource collaborates closely with several campus informatics facilities to support data management for cancer studies. BASE faculty members also develop novel statistical methodologies in response to the needs of JCCC research projects to facilitate such studies. The JCCC BASE Shared Resource was established in 1994. Gang Li, PhD (ZY), an international leader in biostatistics, has been the BASE Director since 2007, and David Elashoff, PhD (ZY) serves as Co-Director. BASE includes five additional faculty members and a staff biostatistician from the UCLA Departments of Biostatistics, Biomathematics, and Medicine. These faculty members are nationally respected biostatisticians with broad expertise in general biostatistics, the design and analysis of clinical trials, bioinformatics, and the analysis and interpretation of high-dimensional high throughput data. During the previous six-year period, the BASE Shared Resource supported projects from 55 JCCC members originating in all six JCCC Research Programs, representing 85% of overall Shared Resource usage. Of this, 64% supported members with peer- review funded research and 21% members without peer-review funded research, resulting in 320 publications, 36% of which were in high-impact (IF ?10, or field leading) journals. The BASE Shared Resource assisted in a large number of cancer grant applications, with 31 successfully awarded for ~$64M in total direct cost funding. In addition, the BASE Shared Resource supported 39 cancer clinical trials during the past six-year project period. The role of the BASE Shared Resource in the facilitation of study design, data analysis, grant applications, protocol review, design, and implementation of clinical trials and data management is central to the mission of the UCLA JCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-44
Application #
9936713
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Black, David S; Cole, Steve W; Christodoulou, Georgia et al. (2018) Genomic mechanisms of fatigue in survivors of colorectal cancer. Cancer 124:2637-2644
Walser, Tonya C; Jing, Zhe; Tran, Linh M et al. (2018) Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78:1986-1999
Chua, Bernadette Anne; Ngo, Jamie Ann; Situ, Kathy et al. (2018) Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515:176-190
Stanton, Annette L; Wiley, Joshua F; Krull, Jennifer L et al. (2018) Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol 86:820-830
Glenn, Beth A; Hamilton, Ann S; Nonzee, Narissa J et al. (2018) Obesity, physical activity, and dietary behaviors in an ethnically-diverse sample of cancer survivors with early onset disease. J Psychosoc Oncol 36:418-436
Tsai, Wen-Ting K; Wu, Anna M (2018) Aligning physics and physiology: Engineering antibodies for radionuclide delivery. J Labelled Comp Radiopharm 61:693-714
Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan et al. (2018) Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors. Nucl Med Biol 61:36-44
Chang, Yu-Ling; Rossetti, Maura; Vlamakis, Hera et al. (2018) A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol :
Kiertscher, Sylvia M; Gangalum, Pallavi R; Ibrahim, Grace et al. (2018) A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol 13:219-229
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009

Showing the most recent 10 out of 767 publications